drugset / Trial / NCT00959972

Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease

NCT00959972

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine if a new drug, varenicline, for smoking cessation is more effective than the standard nicotine replacement therapy aide currently used, "the patch" among smokers hospitalized with coronary heart disease.

Timeline

Start
2009-04
Primary completion
2010-11
Completion
2010-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 21 mg Other
Subject Varenicline Small molecule 1 mg